Histamine and its Effects Mediated via H₃ Receptor – Potential Clinical Applications of H₃ Antagonists

1. White MV. The role of histamine in allergic diseases. J allergy Clin Immunol 1990; 57: 599-605.10.1016/S0091-6749(05)80223-4Search in Google Scholar

2. Greaves MW, Sabroe RU. Allergy and the skin. I - Urticaria Br Med J 1998;57:1147-1150.Search in Google Scholar

3. Friedmann PS. Assessment of urticaria and angio-oedema. Clin Exp Allergy 1999; 57: 109-112.10.1046/j.1365-2222.1999.0290s3109.xSearch in Google Scholar

4. Jutel M, Akdis M, Akdis CA. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy 2009; 39: 1786-1800.10.1111/j.1365-2222.2009.03374.xSearch in Google Scholar

5. Dale HH, Laidlaw PP. The physiological action of beta-imidazolylethylamine. J Physiol 1910; 41: 318-344.10.1113/jphysiol.1910.sp001406Search in Google Scholar

6. Dale HH, Laidlaw PP. Histamine shock. J Physiol. 1919; 52: 355-390.10.1113/jphysiol.1919.sp001837Search in Google Scholar

7. Popielski L. -Imidazolylathylamin und die Organextrakte Erster Teil: -Imidazolylathylamin als mechtiger Errezer der Magendrucken. Pfluegers Arch 1920; 178: 214-236.10.1007/BF01722024Search in Google Scholar

8. Lewis T., Grant T. Vascular reactions of the skin to injury. Part 11. The liberation of histamine - like substance in the injured skin, the underlying cause of factitious urticaria and of wheals produced by burning: and observations upon the nervous control of certain skin reactions. Heart 1924; 11: 209-265.Search in Google Scholar

9. Steinhoff M, Griffiths C, Church M, Lugar TA. Histamine. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. Oxford, United Kingdom: Blackwell Science, 2004: 9. p. 50-52.Search in Google Scholar

10. Best CH., Dale HH., Dudey HW, Thorpe WV. The nature of the vasodilator constituents of certain tissues. J Physiol 1927; 62: 397.10.1113/jphysiol.1927.sp002369Search in Google Scholar

11. Endo Y. Simultaneous induction of histidine and ornithinedecarboxylases and changes in their product amines following the injection of Escherichia coli lipopolysaccharide intomice. Biochem Pharmacol 1982; 31:1643-1647.10.1016/0006-2952(82)90394-XSearch in Google Scholar

12. Szeberényi JB, Pállinger E, Zsinkó M, Pós Z, Rothe G, Orsó E, Szeberényi S, Schmitz G, Falus A, László V. Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunol Lett 2001; 76: 175-182.10.1016/S0165-2478(01)00184-5Search in Google Scholar

13. Radvány Z, Darvas Z, Kerekes K, Prechl J, Szalai C, Pállinger E, Valéria L, Varga VL, Sandor M, Erdei A, Falus A. H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murineTcells. SeminCancer Biol 2000; 10: 41-45.10.1006/scbi.2000.030610888270Search in Google Scholar

14. Shiraishi M, Hirasawa N, Oikawa S, Kobayashi Y, Ohuchi K. Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology 2000; 99:600-606.10.1046/j.1365-2567.2000.00986.xSearch in Google Scholar

15. Maslinski C, Fogel WA. Catabolism of Histamine. In: Uvnäs B, editor. Handbook of experimental pharmacology. Histamine and histamine antagonists. Berlin-Heidelberg: Springer; 1991. P. 165-189.10.1007/978-3-642-75840-9_14Search in Google Scholar

16. Schwelberger HG, Hittmair A, Kohlwein SD. Analysis of tissue and subcellular localization of mammalian diamine oxidase by confocal laser scanning fluorescence microscopy. Inflamm Res 1998; 47 Suppl 1: S60-1.10.1007/s000110050273Search in Google Scholar

17. Schwelberger HG, Bodner E. Purification and characterization of diamineoxidase from porcine kidney and intestine. Biochim Biophys Acta 1997; 1340: 152-164.10.1016/S0167-4838(97)00039-3Search in Google Scholar

18. Bieganski T, Kusche J, Lorenz W, Hesterberg R, Stahlknecht CD, Feussner KD. Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism. Biochim Biophys Acta 1983; 756: 196-203.10.1016/0304-4165(83)90092-2Search in Google Scholar

19. Raithel M, Kufner M, Ulrich P, Hahn EG. The involvement of the histamine degradation pathway by diamineoxidase in manifest gastrointestinal allergies. Inflamm Res 1999; 48 Suppl 1: S75-76.10.1007/s000110050414Search in Google Scholar

20. Klocker J, Matzler SA, Huetz GN, Drasche A, Kolbitsch C, Schwelberger HG. Expression of histamine degrading enzymes in porcine tissues. Inflamm Res 2005; 54(suppl): S54-57.10.1007/s00011-004-0425-7Search in Google Scholar

21. Brown DD, Tomchick R, Axelrod J. The distribution and properties of a histamine-methylating enzyme. J Biol Chem 1959; 234: 2948-2950.10.1016/S0021-9258(18)69701-7Search in Google Scholar

22. Kufner MA, Ulrich P, Raithel M, Schwelberger HG. Determination of histamine degradation capacity in extremely small human colon samples. Inflamm Res 2001; 50(suppl): S96-97.10.1007/PL00022422Search in Google Scholar

23. Schwelberger HG. Histamine N-methyltransferase (HNMT) enzyme and gene. In: Falus A, editor. Histamine: biology and medical aspects. Budapest, Hungary: Spring Med Publishing; 2004. p. 53-59. 24 Yamauchi K, Sekizawa K, Suzuki H, Nakazawa H, Ohkawara Y, Katayose D, Ohtsu H, Tamura G, Shibahara S, Takemura M, et al. Structure and function of human histamine N-methyltransferase: critical enzyme in histamine metabolism in airway. Am J Physiol 1994; 267(3 Pt 1): L342-349.10.1152/ajplung.1994.267.3.L3427943261Search in Google Scholar

25. Vlieg-BoerstraBJ, van der HeideS, Oude Elberink JN, Kluin-Nelemans JC, Dubois AE. Mastocytosis and adverse reactions to biogenic amines and histamine-releasing foods: what is the evidence? Neth J Med 2005; 63: 244-249.Search in Google Scholar

26. Ring J. Angewandte Allergologie. (Implemented allergology.) Munich, Germany: Urban & Vogel; 2004.Search in Google Scholar

27. White MV, Slater J, Kaliner M. Histamine and asthma. Am Rev Respir Dis 1987; 57: 1165-1176.Search in Google Scholar

28. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr 2007; 85: 1185-1196.10.1093/ajcn/85.5.118517490952Search in Google Scholar

29. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem. 2000; 275:36781-3676.10.1074/jbc.M006480200Search in Google Scholar

30. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 2000; 279: 615-620.10.1006/bbrc.2000.4008Search in Google Scholar

31. Milligan G, Bond RA, Lee M.Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 1995; 16:10-13.Search in Google Scholar

32. Ash AS, Schild HO. Receptors mediating some actions of histamine. 1966. Br J Pharmacol. 1997;120(4 Suppl): 302-314, discussion 300-301.Search in Google Scholar

33. Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung WP, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, Edwards JP, Karlsson L. A potent and selective histamine H4 receptor antagonist with antiinflammatory properties. J Pharmacol Exp Ther 2004; 309: 404-413.10.1124/jpet.103.061754Search in Google Scholar

34. LaBella FS, Queen GM, Brandes LJ. Interactive binding at cytochrome P-450 of cell growth regulatory bioamines, steroid hormones, antihormones, and drugs. J Cell Biochem 2000; 76: 686-694.10.1002/(SICI)1097-4644(20000315)76:4<686::AID-JCB16>3.0.CO;2-VSearch in Google Scholar

35. Brandes LJ, Queen GM, LaBella FS. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isoenzymes that metabolize antineoplastic drugs. Cancer ChemotherPharmacol.2000; 45: 298-304.10.1007/s002800050044Search in Google Scholar

36. Paesen GC, Adams PL, Harlos K, Nuttall PA, Stuart DI. Tick histamine-binding proteins: isolation, cloning, and three-dimensional structure. Mol Cell 1999; 3: 661-671.10.1016/S1097-2765(00)80359-7Search in Google Scholar

37. Lieberman P. The basics of histamine biology. Ann Allergy Asthma Immunol 2011; 106 (2 Suppl): 2-5.10.1016/j.anai.2010.08.005Search in Google Scholar

38. Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983; 302: 832-837.10.1038/302832a0Search in Google Scholar

39. Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG. Cloning and Functional Expression of the Human Histamine H3 Receptor Mol Pharmacol 1999; 55: 1101-1107.Search in Google Scholar

40. Bongers G, Bakker RA, Leurs R. Molecular aspects of the histamine H3 receptor. Biochem Pharmacol 2007; 73: 1195-1204.10.1016/j.bcp.2007.01.008Search in Google Scholar

41. Drutel G, Peitsaro N, Karlstedt K, Wieland K, Smit MJ, Timmerman H, Panula P, Leurs R. Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 2001; 59: 1-8.10.1124/mol.59.1.1Search in Google Scholar

42. Tardivel-Lacombe J, Rouleau A, Héron A, Morisset S, Pillot C, Cochois V, Schwartz JC, Arrang JM. Cloning and cerebral expression of the guinea pig histamine H3 receptor: evidence for two isoforms.Neuroreport.2000;11:755-75910.1097/00001756-200003200-00020Search in Google Scholar

43. Bonaventure P, Letavic M, Dugovic C, Wilson S, Aluisio L, Pudiak C, Lord B, Mazur C, Kamme F, Nishino S, Carruthers N, Lovenberg T. Histamine H3 receptor antagonists: from target identification to drug leads. Biochem Pharmacol 2007; 73: 1084-1096.10.1016/j.bcp.2006.10.031Search in Google Scholar

44. Sander K, Kottke T, Stark H. Histamine H3 receptor antagonists go to clinics. Biol Pharm Bull 2008; 31: 2163-2181.10.1248/bpb.31.2163Search in Google Scholar

45. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 2001; 63: 637-672.10.1016/S0301-0082(00)00039-3Search in Google Scholar

46. Zhang M, Venable JD, Thurmond RL. The histamine H4 receptor in autoimmune disease. Expert Opin Investig Drugs 2006; 15: 1443-1452.10.1517/13543784.15.11.144317040202Search in Google Scholar

47. Yu F, Bonaventure P, Thurmond RL. The Future Antihistamines: Histamine H(3) and H(4) Receptor Ligands. Adv Exp Med Biol 2010; 709: 125-140.10.1007/978-1-4419-8056-4_1221618893Search in Google Scholar

48. Tiligada E, Zampeli E, Sander K, Stark H. Histamine H3 and H4 receptors as novel drug targets. Expert Opin Investig Drugs 2009; 18: 1519-1531.10.1517/1472822090318843819758107Search in Google Scholar

49. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 2000; 20: 131-147.10.1023/A:1007074420772Search in Google Scholar

50. Hough LB, Rice FL, H3 receptors and painmodulation: peripheral, spinal, and brain interactions. J Pharmacol Exp Ther 2011; 336: 30-37.10.1124/jpet.110.171264301429820864501Search in Google Scholar

51. Coruzzi G, Poli E, Morini G, Bertaccini G. The Histamine H3 Receptor. In Molecular Targets for Drug Development: GI Diseases. TS Gaginella, A Guglietta, editors. Totowa, NJ: Humana Press; 2000. p. 239-267.10.1007/978-1-59259-202-9_9Search in Google Scholar

52. Coruzzi G, Morini G, Adami M, Grandi D. Role of histamine H3 receptors in the regulation of gastric functions. J Physiol Pharmacol 2001; 52(4 Pt 1): 539-553.Search in Google Scholar

53. Imamura M, Seyedi N, Lander HM, Levi R. Functional identification of histamine H3-receptors in the human heart. Circ Res 1995; 77: 206-210.10.1161/01.RES.77.1.206Search in Google Scholar

54. Hashikawa-Hobara N, Chan NY, Levi R. Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart. J Pharmacol Exp Ther 2012; 340:185-191.10.1124/jpet.111.187765Search in Google Scholar

55. Gruber BL. Mastcells and basophils. In: Sigal LH, Ron Y, editors. Immunology and inflammation: basic mechanisms and clinical consequences New York: McGraw-Hill; 1994. p. 337-351.Search in Google Scholar

56. Suzuki S, Takeuchi K, Majima Y. Localization and function of histamine H3 receptor in the nasal mucosa. Clin Exp Allergy 2008; 38: 1476-1482.10.1111/j.1365-2222.2008.03041.xSearch in Google Scholar

57. Nakaya M, Takeuchi N, Kondo K. Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates. Ann Otol Rhinol Laryngol. 2004; 113: 552-557.10.1177/000348940411300707Search in Google Scholar

58. Varty LM, Gustafsoo E, Laverty M, Hey JA. Activation of histamine H3 receptors in human nasal mucosa inhibits sympathetic vasoconstriction. Eur J Pharmacol 2004; 484: 83-89.10.1016/j.ejphar.2003.10.051Search in Google Scholar

59. Ichinose M, Barnes PJ. Inhibitory histamine H3-receptors on cholinergic nerves in humana airways. Eur J Pharmaco1 1989; 163: 383-386.10.1016/0014-2999(89)90212-4Search in Google Scholar

60. Ichinose M, Stretton C D, SchwaftzJ C, Barnes PJ. Histamine H3-receptors inhibit cholinergic neurotransmission in guinea-pig airways. Br J Pharmacol 1989; 97: 13-1510.1111/j.1476-5381.1989.tb11917.x18544832541854Search in Google Scholar

61. Dimitriadou V, Rouleau A, Dam Trung Tuong M, Newlands GJ, Miller HR, Luffau G, Schwartz JC, Garbarg M. Functional relationship between mast cells and C-sensitive nerve fibres evidenced by histamine H3-receptor modulation in rat lung and spleen. Clin Sci (Lond) 1994; 87: 151-163 10.1042/cs08701517924160Search in Google Scholar